Efficacy and Safety of Aumolertinib as Adjuvant Therapy in Resectable Stage I NSCLC with High-grade Patterns and EGFR Mutations (APPOINT)

被引：0
|
作者：
Han, B. [1 ]
Fang, W. [1 ]
Chen, C. [2 ]
Zhang, W. [1 ]
Zhang, B. [1 ]
Yao, F. [1 ]
Shi, J. [1 ]
Yue, D. [3 ]
Qi, Y. [4 ]
Zhu, Z. [5 ]
Xie, J. [6 ]
机构：
[1] Shanghai Jiao Tong Univ, Affiliated Chest Hosp, Shanghai, Peoples R China
[2] Shanghai Pulm Hosp, Shanghai, Peoples R China
[3] Tianjin Med Univ, Canc Inst Hosp, Tianjin, Peoples R China
[4] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
[5] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Hangzhou, Peoples R China
[6] Putian Coll, Affiliated Hosp, Putian, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
aumolertinib; high-grade patterns; NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.27-09
引用
收藏
页码：S287 / S287
页数：1
相关论文
共 50 条
  • [21] The effect of adjuvant chemotherapy on survival in patients with FIGO stage I high-grade serous ovarian cancer
    van Baal, J.
    Van de Vijver, K.
    Algera, M.
    van der Aa, M.
    Sonke, G.
    van Driel, W.
    Kenter, G.
    Amant, F.
    Lok, C.
    VIRCHOWS ARCHIV, 2019, 475 : S88 - S88
  • [22] Efficacy and Safety of Envafolimab Plus Platinum-based Chemotherapy as Neoadjuvant Therapy in Resectable Stage II-IIIB NSCLC
    Zhang, H.
    Zhao, G.
    Gu, J.
    Ge, D.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S340 - S341
  • [23] Safety and Efficacy of Stereotactic Body Radiation Therapy for Pulmonary Metastases From High-Grade Sarcomas
    Mehta, N. M.
    Selch, M.
    Federman, N.
    Chmielowski, B.
    Lee, J. M.
    Eilber, F. C.
    Wang, P.
    Wu, J.
    Agazaryan, N.
    Lee, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S656 - S656
  • [24] Safety and Efficacy of Stereotactic Body Radiation Therapy for Pulmonary Metastases from High-Grade Sarcomas
    Mehta, N. M.
    Selch, M.
    Federman, N.
    Chmielowski, B.
    Lee, J. M.
    Eilber, F. C.
    Wang, P.
    Wu, J.
    Agazaryan, N.
    Lee, P.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S260 - S260
  • [25] COMBINED MODALITY THERAPY FOR HIGH-GRADE STAGE-I AND STAGE-II LYMPHOMA IMPROVES SURVIVAL
    LEONARD, RCF
    MAUCH, PM
    CANELLOS, GP
    SCOTTISH MEDICAL JOURNAL, 1985, 30 (04) : 269 - 269
  • [26] THE IMPACT OF HISTOLOGY AND ADJUVANT THERAPY ON SURVIVAL AND RECURRENCE PATTERNS AMONG HIGH-GRADE ENDOMETRIAL CANCER WITH RETROPERITONEAL METASTASES
    McEachron, J.
    Marshall, L.
    Tran, V.
    Zhou, N.
    Kanis, M.
    Gorelick, C.
    Lee, Y.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A106 - A107
  • [27] Evaluation of Survival, Recurrence Patterns and Adjuvant Therapy in Surgically Staged High-Grade Endometrial Cancer with Retroperitoneal Metastases
    McEachron, Jennifer
    Marshall, Lila
    Zhou, Nancy
    Tran, Van
    Kanis, Margaux J.
    Gorelick, Constantine
    Lee, Yi-Chun
    CANCERS, 2021, 13 (09)
  • [28] Adjuvant Pelvic Radiation Therapy ± Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma
    Nagar, Himanshu
    Yan, Weisi
    Parashar, Bhupesh
    Nori, Dattatreyudu
    Chao, K. S. C.
    Christos, Paul
    Gupta, Divya
    Holcomb, Kevin
    Caputo, Thomas
    Wernicke, A. Gabriella
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (04): : 335 - 339
  • [29] Presence of High-Grade Subtype Predicts Recurrence of Stage I Lung Adenocarcinoma Only in EGFR-Mutated Patients
    Ichinose, J.
    Kondo, Y.
    Ninomiya, H.
    Yamamichi, T.
    Omura, K.
    Hashimoto, K.
    Matsuura, Y.
    Nakao, M.
    Ishikawa, Y.
    Okumura, S.
    Satoh, Y.
    Mun, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S908 - S908
  • [30] Efficacy and safety of long-term therapy for high-grade glioma with temozolomide: A meta-analysis
    Xu, Weilin
    Li, Tao
    Gao, Liansheng
    Zheng, Jingwei
    Shao, Anwen
    Zhang, Jianmin
    ONCOTARGET, 2017, 8 (31) : 51758 - 51765
12345